Dr. Shyam Panchapakesan, PhD
About Dr. Shyam Panchapakesan, PhD
Dr. Shyam Panchapakesan is a Post Doctoral Associate at Yale University and an Independent Consultant at RxDataScience Inc., specializing in RNA-based technologies and biosensor development. He co-founded Aptamer Innovations and holds patents in his field, contributing to various applications in the pharmaceutical industry.
Work at Yale University
Dr. Shyam Panchapakesan has been serving as a Post-Doctoral Associate at Yale University since 2017. His research focuses on innovative applications in molecular biology, contributing to the academic community in New Haven, Connecticut. His role involves advanced research methodologies and collaboration with other scientists in the field.
Current Consulting Role
Since 2018, Dr. Panchapakesan has worked as an Independent Consultant at RxDataScience Inc. He provides consulting services primarily to clients in the pharmaceutical industry, leveraging his expertise in data science and molecular biology to support various projects and initiatives.
Background in Biotechnology
Dr. Panchapakesan completed his Bachelor of Technology in Biotechnology at Shanmugha Arts, Science, Technology and Research Academy from 2006 to 2010. He further pursued his Doctor of Philosophy in Biochemistry and Molecular Biology at Simon Fraser University, completing his studies in 2017. This educational background laid the foundation for his expertise in RNA-based technologies.
Innovations and Patents
Dr. Panchapakesan developed the fluorescent RNA Mango tag, which has been adapted for various applications and is commercially available. He holds both US and European patents for his work in RNA-based technologies, highlighting his contributions to the field of molecular biology.
Entrepreneurial Ventures
In 2020, Dr. Panchapakesan co-founded Aptamer Innovations, where he continues to apply his knowledge in developing advanced biosensors. His involvement in a Lab-on-a-chip project aims to enhance microbial detection capabilities, showcasing his commitment to innovation in biotechnology.